1012P Intratumoral immunotherapy with a novel TLR1/2/3 agonist, L-pampo, induces robust anti-tumor immune responses and enhances immune checkpoint blockade
Lee, W.S., Kim, D.S., Lee, S.J., Kim, Y.E., Heo, Y.K., Ahn, B.C., Kang, H.G., Cho, J.K., Yum, J.S., Kim, C., Chon, H.J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article